Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

Bibliographic Details
Main Authors:	Andre De Souza, Fabio A. Tavora, Devalingam Mahalingam, Pamela N. Munster, Howard P. Safran, Wafik S. El-Deiry, Benedito A. Carneiro
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Immunology
Subjects:	glycogen synthase kinase-3 (GSK3) glycogen synthase kinase-3 (GSK-3) inhibitor COVID COVID-19 9-ING-41 GSK-3b inhibitor
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.595289/full

Internet